Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial (Q40523247)

From Wikidata
Jump to navigation Jump to search
scientific article published on March 2004
edit
Language Label Description Also known as
English
Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial
scientific article published on March 2004

    Statements

    Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial (English)
    Haku Ishida
    Yuji Inoue
    John B. Wong
    Kiwamu Okita
    1 March 2004
    125-136

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit